AZN · AstraZeneca PLC

Summary

AstraZeneca PLC disclosed its total voting rights as of 30 April 2026 at 1,550,995,630 ordinary shares of US$0.25 each, with no treasury shares, and reported the admission of 14,807 additional ordinary shares to trading on the London Stock Exchange Main Market under its existing employee share schemes block admission.

Key takeaways

• Total voting rights as of 30 April 2026: 1,550,995,630 ordinary shares — serves as denominator for UK disclosure threshold calculations.
• 14,807 new ordinary shares admitted to trading on LSE Main Market between 1–30 April 2026 — issued under employee share schemes.
• All newly admitted shares are fully fungible with existing ordinary shares — no dilutive or structural distinction.
• Admission occurred under the Company’s pre-existing block admission dated 29 January 2021 — no new prospectus or regulatory approval required.